Notes / Company

Hemo Organic Ltd.

HEMORGANIC BSE 524590 ISIN INE422G01015 Pharmaceuticals

Fundamentals

Market cap: ₹6.97 cr
ROE: 0.00%
Debt / equity: -9.77
52-week range: 8.08 — 22.51

Research on Tijori Finance

Company snapshot

Hemo Organic Ltd.

Pharmaceuticals

₹8 cr

Latest quarter · Jun 2026

Sales₹0 cr

Net profit−₹0 cr

Op. margin+0.0%

EPS−₹0.21

Strength & growth

Debt / equity-9.77×

Current ratio1.29×

Sales CAGR+23.8%

The timeline — 2 notes on Hemo Organic Ltd.

July 2026

15 Jul 26 · 5:50 PM IST Brief

Brief · Earnings · Micro cap

Hemo Organic's Q1 revenue nil, auditor flags books again

No revenue from operations for the quarter ended June 2026, down from ₹92.70 lakh in the prior quarter. Net loss narrowed to ₹7.42 lakh but the auditor again qualified the opinion citing unverified trade balances.

May 2026

29 May 26 · 7:34 PM IST Brief

Brief · Earnings · Micro cap

Hemo Organic's revenue fell 63%. Its auditors can't confirm the books.

The specialty-chemicals nano-cap swung to a full-year loss as revenue fell to ₹93.10 lakh. Auditors issued a qualified opinion, and management wrote off all deferred tax assets.

Verify on exchange BSE filings for HEMORGANIC NSE filings for HEMORGANIC Tijori Finance company page